REGN Regeneron Pharmaceuticals, Inc.
NEUTRAL
Impact: 2/10
PRESS-RELEASE
Press release: earnings
Latest settled — T+20d
REGN ▼ -0.31% at T+20d
NEUTRAL call ✗ call lost -0.31% · α vs SPY -10.98% · entry $753.70 → $751.35
Currently $612.14 · -18.78% from $753.70 entry
T+1d
-2.10%
call -2.10% · α -0.42%
$737.85
settled 3mo ago
T+5d
+1.09%
call +1.09% · α -0.54%
$761.95
settled 2mo ago
T+20d
-0.31%
call -0.31% · α -10.98%
$751.35
settled 7w ago
T+60d
—
call — · α —
—
in 9d
Price Chart
Loading chart...
Executive Summary
Regeneron Pharmaceuticals announced it will release its first quarter 2026 financial results on April 29, 2026, followed by a conference call. The press release contains no financial data, guidance, or material operational updates — it is purely a scheduling notice.
Actionable Insight
Traders should await the actual earnings release and call on April 29 for material updates. No action warranted based on this notice alone.
Key Facts
- Regeneron will report Q1 2026 earnings on April 29, 2026, before market open.
- Conference call scheduled for 8:30 AM ET on the same day.
- No financial results, guidance, or operational updates were disclosed in this release.
- This is a routine earnings announcement notice, not a results release.
Financial Impact
None disclosed — no financial data released
Risk Factors
- Earnings could miss consensus expectations given recent insider selling, though minimal in size.
- Potential for volatility post-earnings if guidance is lowered or results disappoint.
Market Snapshot
Exchange
Nasdaq
Analyst Consensus
75% bullish (36 analysts)
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3262579 |
14 reports for REGN
25%
Hit rate
best @ T+1▲ +1.29%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 31, 2026
12d ago
|
ANALYST-UPGRADE
| $810.25 $752.29 | ▼ −7.15% | ▼ −7.28% | $612.14 (−24.45%) |
|
May 21, 2026
22d ago
|
Press Release
| $638.53 $600.65 | ▼ −5.93% | ▼ −7.59% | $612.14 (−4.13%) |
|
May 18, 2026
25d ago
|
ANALYST-DOWNGRADE
| $629.34 $632.17 | ▼ −0.45% | ▲ +1.17% | $612.14 (+2.73%) |
|
May 18, 2026
26d ago
|
Press Release
| $629.34 $632.17 | ▲ +0.45% | ▼ −1.17% | $612.14 (−2.73%) |
|
May 16, 2026
28d ago
|
Press Release
| $629.34 $632.17 | ▼ −0.45% | ▲ +1.17% | $612.14 (+2.73%) |
|
May 15, 2026
28d ago
|
Press Release
| $696.20 $638.53 | ▼ −8.28% | ▼ −9.25% | $612.14 (−12.07%) |
|
May 1, 2026
6w ago
|
ANALYST-UPGRADE
| $810.25 $752.29 | ▼ −7.15% | ▼ −7.28% | $612.14 (−24.45%) |
|
Apr 24, 2026
7w ago
|
DEFA14A
| $744.35 $709.19 | ▼ −4.72% | ▼ −5.12% | $612.14 (−17.76%) |
|
Apr 21, 2026
7w ago
|
Press Release
| $747.15 $729.36 | ▼ −2.38% | ▼ −3.46% | $612.14 (−18.07%) |
|
Apr 13, 2026
8w ago
|
Press Release
| $745.61 $749.26 | ▲ +0.49% | ▼ −2.81% | $612.14 (−17.90%) |
Showing 10 of 14
US Market Status
Market Closed — Opens Mon (48h 51m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access